Allspring Global Investments Holdings, LLC Verrica Pharmaceuticals Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$3.75 - $7.46 $23,546 - $46,841	6,279 New	6,279 $24,000
Q2 2022 Jul 25, 2022	SELL	$1.81 - $8.93 $9,250 - $45,641	-5,111 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$7.59 - $9.49 $4,493 - $5,618	-592 Reduced 10.38%	5,111 $41,000
Q4 2021 Jan 28, 2022	BUY	$9.1 - $13.36 $51,897 - $76,192	5,703 New	5,703 $52,000

Others Institutions Holding VRCA

# of Institutions

Shares Held

17.4M

Call Options Held

6.1K

Put Options Held

6.3K

Perceptive Advisors LLC New York, NY

7.1M
Shares

$56.4 Million
1.5% of portfolio
Avoro Capital Advisors LLC New York, NY

4M
Shares

$31.8 Million
0.4% of portfolio
Vanguard Group Inc Valley Forge, PA

1.27M
Shares

$10.1 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.13M
Shares

$8.98 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

463K
Shares

$3.68 Million
0.0% of portfolio

View Full List

About Verrica Pharmaceuticals Inc.

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

More about VRCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account